A recent study finds that while many caregivers believe taking care of a loved one at home has provided more meaning in their life, a majority often feel alone, exhausted, frustrated and overwhelmed.
Metabolic Solutions Development Co. LLC announced that Jerry Colca, co-founder and chief scientific officer of MSDC, presented results of a Phase 2a study at the 14th International Conference on Alzheimer’s Drug Discovery.
Police are asking for the public’s help in finding a missing 79-year-old Farmington Hills man with Alzheimer’s disease.
A senior University of Michigan medical school faculty member linked to a $276 million insider trading case has retired.
Radiation is often thought of for just treating cancer, but a new groundbreaking Beaumont study finds in mice that it can treat Alzheimer’s.
A Grand Valley State University faculty member received a National Institutes of Health grant to continue researching how patients with Alzheimer’s disease use visual cues to navigate their living areas.
Metabolic Solutions Development Co. LLC will provide an update on the clinical evaluation of MSDC-0160, a compound being investigated in an ongoing Phase 2a trial in subjects with mild to moderate dementia due to Alzheimer’s disease, at the Alzheimer’s Drug Discovery Foundation 13th International Conference on Alzheimer’s Drug Discovery in Jersey City, N.J. Sept. 10.
An Alzheimer’s patient is missing and Inkster police are asking for your help in finding her.
Tetra Discovery Partners LLC, a developer of new treatments for major neurological conditions based on PDE4 modulation in the brain, announced it has been awarded a five-year cooperative agreement by the National Institutes of Health.
The University of Michigan Health System has established a new phone number that connects patients and their families and friends to University of Michigan memory loss and dementia services.